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  الفصل األول
  قواعد محاية منتجات األدوية 
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  املبحث األول
  قواعد محاية املنتجات الدوائية ومدى محاية 
  االستعماالت اجلديدة للدواء يف الدول الصناعية
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(3)  Braga. C.P Strengthen Protection of Intellectual property in Developing countries. Washington 
Dc 1990 p.47 
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(4)  Levin, M EPC och Nationellratt. Stockholm. Sweden 2004 p 162..
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(6)   Malmberg. L. Nyhetskravet I patentratteen, Stockholm Univesity 2005 p. 69.
(7)  Bruchhausen, K, the second Medical use of Medicaments- 1611c (No.3.1.1985), p 306.  
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(12) HUNI , A, the Patentability of pharmaceutical uses of known how prop (No. 7/8. 1986) Geneva. 
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(13)  Industri Forbundet, Immaterial ratt (EES) och (EG) Industri forbunet, Stockholm 2003 p.21. 
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(14)  Phillips, J, Introduction to intellectual property. 2 and Edition Butterworth's, London 1990, 
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(15)  Reiland, G, om Patentering och Pattenteskydd 1 sverige. Jurisforlaget Stockholm 1984. p14. 
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(16)  Domeij. B oversiket over Europe- Praxis Betrafande nyhet, uppfining Medecinska fotfaranda, 
N.66 Sweden 1997 p149.. 
(17)  E.P.H Bayer AG. Decision of Patent Appeal. Sweden 13/7/1998, E.P. H, 2nd Edition p.122.. 
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(19)  Memo of European Commission 10/294 Brussels, 1jilu 2010 (See IP/05/737).. 
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(20)  Nilsson, A. India and TRIPS Stockholm. Sweden 2004 p. 23. 
(21)  Sharma, D, GAAT and India. Konarkpulisheres. Delhi 1994 p25.. 
33
Al-Salihi: ????? ????? ?????? ??????? ???? ????? ??????????? ??????? ??? ?? ??????? ??????? ??????????? ???????
Published by Scholarworks@UAEU, 2011
] 











 [                     ] 

  
   [ 
 
 .	
 R  ;. HIV  5 J 7	
 	
 L<  +	






 D: ;. /5

























 D.  ?

 @
 >/ 5 5 @
 -	
%%a.  







 )F 7  2
 	




  E85 F	
 H8	
 1=	.  
  :الربازيل: ثانياً
76





 J -: +, +)
 D	N#  DJ  -	
) ( D	NN'  1= @
  














 	 3/  
 @




 7 * ]Q 
 )@
 ) )	  . H<  7, 7< *	 Y	
 = (	
 "
 " < 7,
/ 1 D	 

 >/  2< C	

 )@
 ) ) o)














 [                  ] 

 





 )	 ;	<  








 1 ;. ?
.2 77









 5 7N#N 	 DNNP   6 	

 ;)	< 	
   	 C75 1= @
  ;	< 	
 1=
   . 	
 389 C+		
 -	
 +, "V##  D	N# 
q D	 )	
 ;F)



























 )59 )	 -J  ,
	








 = R, 	e  )=9	
 )	
 =
 1) ;). ),
	
 7 		
























6 1 	  SC  )=	
 ;. E Fe
S	
 . ;	< @
 -5 * +		
 +	
`  =), +) )7@






                                      
(22)  Gosain, R Patent Law Reform in brazel- An Update PW (Issue, 66. 1994).p 39.. 
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(36)  Bagchi A. K sydligit prespektiv pa Gatt avtalet Ab, uppsalw Seden 2006 p. 144. . 
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(37)  Ahnlid, a, fran Gatt till wato internationlla studier stockholm 2004 p. 165 . 
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Interpretation of the 
EPC/Vienna Convention - 
therapeutically use claims 
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Decision of 05.12.1984 
OJ EPO 1985, 64 
Art. 108, third sentence, 
112(1), 122 EPC 
"Re-establishment of rights of 
opponent/VOEST ALPINE" 
- Re-establishment of rights of 
appellant as opponent - Time 
limit for filing grounds of 
appeal 
G 1/86 
Decision of 24.06.1987 
OJ EPO 1987, 447 
Art. 102(3), 107 EPC 
R. 58(4) EPC 
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silence/HOECHST" 
Admissibility of appeal by 
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58(4) - Application of Rule 
58(4) 
G 1/88 
Decision of 27.01.1989 
OJ EPO 1989, 189 
Art. 54, 64, 69, 112(1)(a), 
123 EPC 
"Friction reducing 
additive/MOBIL OIL III" 
Amendment in opposition 
proceedings - change of 
category (here: from 
"compound" and 
"composition" to "use of 
compound for a particular 
purpose") - Novelty of such a 
use claim over disclosure of 
same compound for different 
purpose - Second non-medical 
indication 
G 2/88 
Decision of 11.12.1989 
OJ EPO 1990, 93 
Corr. OJ EPO 1990, 469 
Art. 99(4), 112(1)(a) EPC  
R. 60(2) EPC 
"Transfer of opposition/MAN" 
Transfer of rights - status of 
party in opposition 
proceedings - dissolution of 
G 4/88 
Decision of 24.04.1989 
OJ EPO 1989, 480 
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opposing company - legal 
person 




Treatment of documents 
intended for the EPO and 
received by the German Patent 
Office in Berlin - Functions 
and powers of the President - 
Principle of good faith - 
Protection of the legitimate 
expectations of users of the 
EPO 
G 5/88, G 7/88, G 8/88 
Decision of 16.11.1990 
OJ EPO 1991, 137 
Art. 54, 69, 112(1)(a) EPC "Plant growth regulating 
agent/BAYER"  
Second non-medical indication 
- Novelty of second non-
medical use with same 
technical means of execution 
G 6/88 
Decision of 11.12.1989 
OJ EPO 1990, 114 
Art. 112(1)(a) and (b), 
154(3) EPC 
Art. 17(3)(a) PCT 
R. 13, 33, 40 PCT 
"Polysuccinate esters" 
Competence of the Enlarged 
Board of Appeal in protest 
cases under the PCT - Non-
unity a posteriori 
G 1/89 
Decision of 02.05.1990 
OJ EPO 1991, 155 
Art. 112(1)(b), 154(3) EPC 
Art. 17(3)(a) PCT 
R. 13, 33, 40 PCT 
Non-unity a posteriori 
Competence of the Enlarged 
Board of Appeal in protest 
cases under the PCT - Non-
unity a posteriori 
G 2/89 
Opinion of 02.05.1990 
OJ EPO 1991, 166 
Art. 100(c), 117(1), 123(1) 
(2), 138(1)(c) EPC 
R. 86, 88, second sentence, 
EPC 
"Correction under Rule 88, 
second sentence, EPC" 
Correction of the parts of a 
European patent application or 
of a European patent relating 
to the disclosure 
G 3/89 
Opinion of 19.11.1992 
OJ EPO 1993, 117 
Art. 102(4)(5), 106, 
112(1)(b) EPC 
R. 58(5), 69(1) EPC 
"Revocation of the patent" 
Revocation of the patent by a 
decision - Revocation, failure 
to meet formal requirements 
when the patent is maintained 
as amended - Termination of 
opposition proceedings - Loss 
G 1/90 
Opinion of 05.03.1991 
OJ EPO 1991, 275 
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of rights - legal fictions 
Art. 21 EPC 
R. 9(3) EPC 
"Responsibility of the Legal 
Board of 
Appeal/KOLBENSCHMIDT" 
Responsibility of the Legal 
Board of Appeal - Appeals 
against decisions of the 
formalities officer 
G 2/90 
Decision of 04.08.1991 
OJ EPO 1992, 10 
Art. 82, 102(3) EPC 
R. 61a EPC 
"Unity/SIEMENS"  
Unity in opposition - legally 
irrelevant 
G 1/91 
Decision of 09.12.1991 
OJ EPO 1992, 253 
Art. 107 EPC "Appeal fees/KROHNE" 
Reimbursement of appeal fees 
where several parties have 
filed an appeal 
G 2/91 
Decision of 29.11.1991 
OJ EPO 1992, 206 
Art. 78(2), 79(2), 122(5), 
157(2)(b), 158(2) EPC 
R. 104b(1)(b)(c) EPC 
(R. 107(1)(c)(e) EPC) 
(see however G 5/93) 
"Re-establishment of 
rights/FABRITIUS II" 
Applicability of Article 122(5) 
EPC to the time limits under 
Rule 104b(1)(b) and (c) EPC 
(R. 107(1)(c) and (e) EPC) 
together with Articles 
157(2)(b) and 158(2) EPC 
G 3/91 
Decision of 07.09.1992 
OJ EPO 1993, 8 
Art. 105, 107 EPC "Intervention/DOLEZYCH II" 
Intervention (in opposition 
proceedings by an assumed 
infringer) 
G 4/91 
Decision of 03.11.1992 
OJ EPO 1993, 707 
Art. 19(2), 24 EPC "Appealable 
decision/DISCOVISION" 
Suspected partiality of a 
member of an Opposition 
Division - ground of appeal? 
G 5/91 
Decision of 05.05.1992 
OJ EPO 1992, 617 
Art. 14(2) and (4) EPC 
R. 6(3) EPC 
"Fee reduction/ASULAB" 
Entitlement to fee reduction 
G 6/91 
Decision of 06.03.1992 
OJ EPO 1992, 491 
Art. 113(2), 114(1) EPC 
R. 60(2), 66(1) EPC 
"Withdrawal of appeal/BASF" 
Effect of withdrawal of the 
appeal (by the sole appellant, 
who was the opponent in the 
first instance) 
G 7/91 
Decision of 05.11.1992 
OJ EPO 1993, 356 
Art. 113(2), 114(1) EPC 
R. 60(2), 66(1) EPC 
"Withdrawal of appeal/BELL" 
Effect of withdrawal of the 
G 8/91 
Decision of 05.11.1992 
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appeal (by the sole appellant) OJ EPO 1993, 346 
Corr. OJ EPO 1993, 478 
Art. 101, 102, 110, 114 
EPC 
R. 55, 56 EPC 
"Power to examine/ROHM 
AND HAAS" 
Extent of power to examine 
opposition 
G 9/91 
Decision of 31.03.1993 
OJ EPO 1993, 408 
Art. 99 to 102, 110, 114 
EPC 
R. 55, 56, 66 EPC 
"Examination of 
oppositions/appeals"  
Extent of obligation and power 
to examine grounds for 
opposition 
G 10/91 
Opinion of 31.03.1993 
OJ EPO 1993, 420 
Art. 100(c), 117(1), 
123(1)(2), 138(1)(c) EPC 
R. 86 and 88, second 
sentence, EPC 
"Glu-Gln/CELTRIX" 
Correction of errors 
 
G 11/91 
Decision of 19.11.1992 
OJ EPO 1993, 125 
R. 68 EPC "Final decision/NOVATOME 
II" 
Conclusion of written 
proceedings - Handing over of 
decision by formalities section 
to EPO postal servic 
G 12/91 
Decision of 17.12.1993 
OJ EPO 1994, 285 
Art. 54(2), 112(1)(b) EPC "Availability to the public" 
Novelty - state of the art - 
availability - composition of 
product - public prior use 
G 1/92 
Opinion of 18.12.1992 
OJ EPO 1993, 277 
Art. 82 EPC 
R. 46 EPC 
"Non-payment of further 
search fees" 
Lack of unity of invention - 
consequences of non-payment 
of further search fees 
G 2/92 
Opinion of 06.07.1993 
OJ EPO 1993, 591 
Art. 60, 61, 167 EPC 
R. 13, 14, 15, 16 EPC; 
Art. 1, 9 Protocol on 
Recognition; 
Art. 12a RPEBA 
"Unlawful 
applicant/LATCHWAYS" 
Dissenting opinion - Final 
decision by a national court - 
Party other than applicant 
entitled to patent - Third 
parties' interests - Withdrawal 
of original application by 
unlawful applicant - Filing of 
new application by lawful 
applicant 
G 3/92 
Decision of 13.06.1994 
OJ EPO 1994, 607 
Art. 113(1), 114(1)(2) EPC "Basis of decisions" G 4/92 
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R. 71(2) EPC Right to comment - Party 
absent from oral proceedings 
Opinion of 29.10.1993 
OJ EPO 1994, 149 
Art. 122(5) EPC "Re-establishment/HOUPT" 
Applicability of Article 122(5) 
EPC 
G 5/92 
Decision of 27.09.1993 
OJ EPO 1994, 22 
Art. 122(5) EPC "Re-
establishment/DURIRON" 
Applicability of Article 122(5) 
EPC 
G 6/92 
Decision of 27.09.1993 
OJ EPO 1994, 25 
Art. 101(2), 107, 111, 
114(1) EPC 
R. 58(2), 64(b), 65(1), 
66(1) EPC 
"Non-appealing party/BMW" 
Reformatio in peius - Patent 
maintained in amended form in 
accordance with auxiliary 
request - Opposing parties 
each adversely affected - 
Appeal by one party - 
Requests by a non-appealing 
party which go beyond the 
appellant's requests in the 
notice of appeal - Minority 
opinion 
G 9/92; G 4/93 
Decision of 14.07.1994 
OJ EPO 1994, 875 
R. 25 EPC "Divisional application" Filing 
of divisional application: time 
limit 
G 10/92 
Opinion of 28.04.1994 
OJ EPO 1994, 633 




Conflicting requirements of 
Article 123, paragraphs 2 and 
3, EPC 
G 1/93 
Decision of 02.02.1994 
OJ EPO 1994, 541 
Art. 83 EPC 
R. 28 EPC 
"Hepatitis A Virus/UNITED 
STATES OF AMERICA II" 
Sufficiency of disclosure - 
Culture deposit information 
G 2/93 
Decision of 21.12.1994 
OJ EPO 1995, 275 
Art. 54(2), 87 to 89 EPC "Priority interval" 
Priority - document published 
during the priority interval - 
State of the art - document 
published during the priority 
interval - Invalid priority - 
different invention - Obiter 
G 3/93 
Opinion of 16.08.1994 
OJ EPO 1995, 18 
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dictum - admissibility of the 
referral 
Art. 122(5), 150, 157(2)(b), 
158(2) EPC 
R. 104b(1)(b), EPC 
(R. 107(1)(c) EPC) 
"Re-
establishment/NELLCOR" 
Applicability of Article 122(5) 
EPC 
G 5/93 
Decision of 18.01.1994 
OJ EPO 1994, 447 
Art. 96(2), 113(2), 123(1), 
167(2) EPC 




Amendments after a Rule 
51(6) communication - 
discretion of Examining 
Divisions - Reservations under 
Article 167(2) EPC 
G 7/93 
Decision of 13.05.1994 
OJ EPO 1994, 775 
Art. 114(1) EPC 
R. 60(2), 66(1) EPC 
"Withdrawal of 
opposition/SERWANE II" 
Withdrawal of opposition 
without withdrawal of appeal - 
Termination of appeal 
proceedings 
G 8/93 
Decision of 13.06.1994 
OJ EPO 1994, 887 
Art. 99 EPC "Opposition by patent 
proprietor/PEUGEOT AND 
CITROEN" 
Opposition filed by proprietor 
against own patent - 
receivability 
G 9/93 
Decision of 06.07.1994 
OJ EPO 1994, 891 
Art. 96(2), 97(1), 110, 
111(1), 114(1) EPC 
"Scope of examination in ex 
parte appeal/ 
SIEMENS"  
Inclusion of new grounds in ex 
parte  
proceedings - Reformatio in 
peius 
G 10/93 
Decision of 30.11.1994 
OJ EPO 1995, 172 
Art. 105 EPC "Intervention/ALLIED 
COLLOIDS" 
Admissibility of intervention 
during appeal proceedings 
G 1/94 
Decision of 11.05.1994 
OJ EPO 1994, 787 
Art. 116,133, 134 EPC "Representation/HAUTAU II" 
Oral submissions by an 
accompanying person in ex
parte proceedings - Oral 
submissions by a former 
member of the board of appeal 
G 2/94 
Decision of 19.02.1996 
OJ EPO 1996, 401 
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in either ex parte or inter 
partes proceedings 
Art. 99, 100(a) (b) (c), 
114(1) EPC 
R. 55, 56 EPC 
"Fresh grounds for 
opposition/DE LA RUE" 
No power to examine fresh 
grounds for opposition without 
agreement of patentee 
G 1/95 
Decision of 19.07.1996 
OJ EPO 1996, 615 
Art. 14(1)(2), 80(d), 87(2), 
100(c), 123(2), 138(1)(c), 
164(2) EPC 
Art. 4A(2) Paris 
Convention 
R. 88 EPC 
R. 91.1(c) PCT 
"Replacement of application 
documents/ATOTECH" 
Substitution of complete 
documents forming an 
application by other 
documents by way of a 
correction under Rule 88 EPC 
(no) 
G 2/95 
Decision of 14.05.1996 
OJ EPO 1996, 555 
Art. 53(b), 112(1)(b) EPC "Inadmissible referral" 
Patentability of plant and 
animal varieties - No 
conflicting decision - 
Inadmissible referral by the 
President of the EPO 
G 3/95 
Opinion of 27.11.1995 
OJ EPO 1996, 169 
Art. 116, 117, 133, 134 
EPC 
"Representation/BOGASKY" 
Oral submission by an 
accompanying person in 
opposition or opposition 
appeal proceedings 
G 4/95 
Decision of 19.02.1996 
OJ EPO 1996, 412 
Art. 23, 33(1)(b), 112(1)(a), 
164(2) EPC 
Art. 11(2), 18 RPBA 
R. 10(2), 11, 66(1), 71, 
71a(1) EPC 
"Interpretation of Rule 71a(1) 
EPC/GE CHEMICALS" 
Interpretation of Rule 71a(1) 
EPC vis-à-vis the boards of 
appeal 
G 6/95 
Decision of 24.07.1996 
OJ EPO 1996, 649 
Art. 99, 100(a)(b)(c), 
114(1) EPC 
R. 55, 56 EPC 
"Fresh grounds for 
opposition/ETHICON" 
No power to examine fresh 
grounds for opposition without 
agreement of patentee 
G 7/95 
Decision of 19.07.1996 
OJ EPO 1996, 626 
Art. 21(3) EPC 
R. 89 EPC 
"Correction of decision to 
grant/US GYPSUM II" 
Relative competence of the 
Technical and Legal Boards of 
Appeal - Refusal of a 
correction of the decision to 
G 8/95 
Decision of 16.04.1996 
OJ EPO 1996, 481 
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grant 
Art. 21, 23(1) (3), 24, 
106(1), 110(1), 111(1), 113, 
114, 116, 121, 122, 125, 
127 EPC 
R. 10(2), 11, 65(1), 66(2), 
67, 89, 90, 92(1) (2) EPC 
Art.: 10 RPBA 
Art.: 11a, 11b RPEBA 
Art.: 23 RDR 
Art.: 31, 32, 62 (5) TRIPS 
Art.: 31 (3) Vienna 
Convention on the Law of 
Treaties 
"Request with a view to 
revision/ETA" 
Administrative or 
jurisdictional measures to 
be taken in response to 
requests based on the 
alleged violation of a 
fundamental procedural 
principle and aimed at the 
revision of a final decision 
taken by a board of appeal 
having the force of res judicata 
- Entry in the Register of 
European Patents 
G 1/97 
Decision of 10.12.1999 
OJ EPO 2000, 322 
Art. 112(1)(a), 108 EPC 
R. 69(1) EPC 
"Good faith/UNILEVER" 
Fee for appeal - Principle of 
good faith - Principle of the 
protection of legitimate 
expectations 
G 2/97 
Decision of 12.11.1998 
OJ EPO 1999, 123 
Art. 99 
R. 55 
"Opposition on behalf of a 
third party/INDUPACK" 
Admissibility of opposition - 
acting on behalf of a third 
party - Circumvention of the 
law by abuse of process 
G 3/97 
Decision of 21.01.1999 
OJ EPO 1999, 245 
Art. 99 
R. 55 
"Opposition on behalf of a 
third party/GENENTECH" 
Admissibility of opposition - 
acting on behalf of a third 
party - Circumvention of the 
law by abuse of process 
G 4/97 
Decision of 21.01.1999 
OJ EPO 1999, 270 
Art. 52, 53(b), 54, 64(2) 
EPC 
R. 23b EPC 
Art. 2(b) Strasbourg Patent 
Convention 
Art. 2 UPOV Convention 
1961 




Claims comprising but not 
identifying plant varieties - 
Plant varieties as products of 
recombinant gene technology - 
Article 64(2) EPC not relevant 
for examination of product 
claims 
G 1/98 
Decision of 20.12.1999 
OJ EPO 2000, 111 
Art. 54(2)(3), 56, 60(2), 83, "Requirement for claiming G 2/98 
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84, 87(1)EPCArt 87(4), 
88(2) (3) (4), 89, 93, 
112(1)(b), 123(2)(3) EPC 
Art. 4A(1), 4C(4), 4F, 4H, 
19 Paris Convention  
Art. 11b RPEBA 
priority of the "same 
invention"" 
Interpretation of the concept of 
"the same invention" referred 
to in Article 87(1) EPC - 
Consistency of the 
interpretation with the Paris 
Convention and the EPC - 
Conformity of the 
interpretation with principles 
of equal treatment and legal 
certainty and with the 
requirement of consistency as 
regards assessment of novelty 
and inventive step 
Opinion of 31.05.2001 
OJ EPO 2001, 413 
Art. 54(2)(3), 55(1)(a), 56, 
89, 112(1)(a) EPC 
R. 23 EPC 
Art. 17(2) RPBA 
Art. 2, 4 Paris Convention 
Art. 4 SPC 




Admissibility of referral - 
significance of the point of law 
in the appeal proceedings (yes) 
- Calculation of the six-month 
period under Article 55 EPC - 
relevant date - date of actual 
filing of the application 
G 3/98 
Decision of 12.07.2000 
OJ EPO 2001, 62 
Art. 66, 67, 76, 79, 80, 90, 
91, 112 EPC 
R. 15, 25, 85a, 107, 108 
EPC 
Art. 4 Paris Convention  
"Designation fees" 
Failure to pay designation fees 
- No retroactive effect of 
deemed withdrawal except for 
Article 67 EPC - Deemed 
withdrawal takes effect upon 
expiry of the time limit for 
payment of designation fees 
G 4/98 
Opinion of 27.11.2000 
OJ EPO 2001, 131 
Art. 100, 101(1), 
102(1)(2)(3), 106(1), 107, 
108, 112(1)(a), 114(1), 
123(2), 123(3), 125 EPC 
R. 57a , 58(2), 64(b), 66(1), 
87 EPC 
"Reformatio in peius / 3M" 
Reformatio in peius - 
exception to the prohibition - 
Status of appellant/opponent - 
Status of appellant/patent 
proprietor 
G 1/99 
Decision of 02.04.2001 
OJ EPO 2001, 381 
Art. 54(2)(3), 55(1)(a), 56, 
89 and 112(1)(a) EPC 
R. 23 EPC 
Art. 17(2) RPBA 
"Six-month period/DEWERT" 
Admissibility of referral - 
significance of the point of law 
in the appeal proceedings (yes) 
G 2/99 
Decision of 12.07.2000 
OJ EPO 2001, 83 
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Art. 2, 4 Paris Convention 
Art. 4 SPC 
Art. 6 ECHR 
- Calculation of the six-month 
period under Article 55 EPC - 
relevant date - date of actual 
filing of the application 
Art. 58, 99, 99(1), 104, 107, 
110(1), 112(1)(a), 133, 
133(4), 134 EPC 
R. 1, 26(2)(c), 36(3), 55, 
55(a), 56(2), 60(2), 66(1), 
100, 100(1) EPC 
"Admissibility of joint 
opposition or joint 
appeal/HOWARD FLOREY" 
Admissibility - Fee for 
opposition - persons acting in 
common in filing notice of 
opposition - common 
opposition - joint opposition 
Admissibility - Fee for appeal 
- persons acting in common in 
filing notice of appeal - 
common appeal - joint appeal - 
Common representative 
G 3/99 
Decision of 18.02.2002 
OJ EPO 2002, 347 
Art. 10(2)(a), 10(2)(i), 15, 
18(2), 19, 19(1), 19(2), 21, 
21(3)(a), 21(3)(b), 21(3)(c), 
21(4), 33(3), 90, 91, 91(3), 
99(1), 102(5), 106, 
112(1)(b), 164(2) EPC 
R. 9, 9(3), 51(4), 55(c), 
56(1), 56(2), 56(3), 57(1), 
69(1), 69(2) EPC 
Notice of the Vice-
President of Directorate-
General 2 dated 28.4.1999, 
points 4 and 6 
"Formalities officers´ powers" 
Opposition divisions - 
formalities officers - decisions 
- powers 
G 1/02 
Opinion of 22.01.2003 
OJ EPO 2003, 165 
Art. 23(3), 33, 66, 87(1) 
and EPCArt 87(5), 88, 
112(1)(a), 150(2), 172 EPC 
Art. 8 PCT 
R. 4.10 PCT  
Art. 1 - 12, 4A(2), 19 Paris 
Convention 
Art. 5, 26, 34, 38 
Vienna Convention 1969 
Art. 34, 35, 38 Vienna 
Convention 1986 
Art. 1, 2 (1) TRIPS 
"Priorities from 
India/ASTRAZENECA" 
International applications - 
priorities from India - 
Applicability of Article 87(5) 
EPC - The position under the 
PCT - The EPO not party to 
TRIPS - Interpretation of 
Article 87 EPC - according to 
principles of public 
international law - in the light 
of obligations of contracting 
G 2/02 and G 3/02 
Decision of 26.04.2004 
OJ EPO 2004, 483 
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Agreement 
Art. 38 Statute, 
International Court of 
Justice 
Art. 27 Universal 
Declaration of Human 
Rights 
states under TRIPS 
Art. 52, 53, 54(2), (3) and 
(4), 56, 57, 60(2), 84, 87(1), 
112(1), 123(2) and (3), 
139(2) EPC  
R. 27(1)(b), 29(1) EPC 
"Disclaimer/PPG" 
Allowability of disclaimers - 
delimitation against state of the 
art under Article 54(2) and (3) 
(4) – 
accidental anticipation - 
exclusion of subject-matter not 
eligible for patent protection 
Drafting of disclaimers - 
requirements of clarity and 
conciseness 
G 1/03 
Decision of 08.04.2004 
OJ EPO 2004, 413 
Art. 52, 53, 54(2), (3) and 
(4), 56, 57, 60(2), 84, 87(1), 
112(1), 123(2) and (3), 
139(2) EPC  
R. 27(1)(b), 29(1) EPC 
"Disclaimer/GENETIC 
SYSTEMS" 
Allowability of disclaimers - 
delimitation against state of the 
art under Article 54(2) and (3) 
(4) - accidental anticipation - 
exclusion of subject-matter not 
eligible for patent protection 
Drafting of disclaimers - 
requirements of clarity and 
conciseness 
G 2/03  
 
Decision of 08.04.2004 
OJ EPO 2004, 448 
Art. 21, 106, 107, 108, 109, 
111(1) and 112(1) EPC  
R. 67 EPC 
Art. 11 RFees 
"Reimbursement of the appeal 
fee//HIGHLAND" 
Interlocutory revision and 
request for reimbursement of 
the appeal fee - department of 
the first instance not competent 
to refuse the request for 
reasons of equity - competence 
of the board of appeal which 
would have been competent to 
decide on the substantive 
issues of the appeal in the 
absence of interlocutory 
revision 
G 3/03 
Decision of 28.01.2005 
OJ EPO 2005, 344 
94
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  املصادر واملراجع
  :املصادر العربية: أوالً
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